140 related articles for article (PubMed ID: 37861502)
1. Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis.
Jin Y; Wang M; Liu Y; Xu A
Medicine (Baltimore); 2023 Oct; 102(42):e35617. PubMed ID: 37861502
[TBL] [Abstract][Full Text] [Related]
2. Anti-mitochondrial antibodies detection assays for diagnosis of primary biliary cholangitis in southern Tunisia population.
Mejdoub S; Hamza Z; Hachicha H; Chtourou L; Marrzouk S; Feki S; Jerbi A; Boukthir S; Bahloul Z; Tahri N; Masmoudi H
Ann Biol Clin (Paris); 2022 Sep; 80(5):423-429. PubMed ID: 36453746
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
[TBL] [Abstract][Full Text] [Related]
5. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies.
Öztürk Ö; Dos Santos Duarte SD; Balaban HY; Şimşek H; Şener B
Turk J Med Sci; 2022 Apr; 52(5):1697-1703. PubMed ID: 36422475
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
[TBL] [Abstract][Full Text] [Related]
7. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis.
Villalta D; Seaman A; Tiongson M; Warren C; Bentow C; Bizzaro N; Alessio MG; Porcelli B; Norman GL; Mahler M
Clin Chem Lab Med; 2020 Aug; 58(9):1499-1507. PubMed ID: 32286240
[TBL] [Abstract][Full Text] [Related]
9. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
[TBL] [Abstract][Full Text] [Related]
10. Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis.
John BV; Dahman B; Deng Y; Khakoo NS; Taddei TH; Kaplan DE; Levy C
Liver Int; 2022 Feb; 42(2):384-393. PubMed ID: 34614294
[TBL] [Abstract][Full Text] [Related]
11. Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients.
Zografos TA; Gatselis N; Zachou K; Liaskos C; Gabeta S; Koukoulis GK; Dalekos GN
World J Gastroenterol; 2012 Sep; 18(34):4721-8. PubMed ID: 23002341
[TBL] [Abstract][Full Text] [Related]
12. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
[No Abstract] [Full Text] [Related]
13. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis.
Saito H; Takahashi A; Abe K; Okai K; Katsushima F; Monoe K; Kanno Y; Ohira H
Fukushima J Med Sci; 2012; 58(2):107-16. PubMed ID: 23237866
[TBL] [Abstract][Full Text] [Related]
14. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients.
Florin L; Rubben K; Vanhaecke A; Devreese K; De Keyser F; Smith V; Bonroy C
Clin Chem Lab Med; 2020 Feb; 58(3):416-423. PubMed ID: 31714880
[TBL] [Abstract][Full Text] [Related]
16. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?
Nakajima M; Shimizu H; Miyazaki A; Watanabe S; Kitami N; Sato N
J Gastroenterol; 1999 Oct; 34(5):607-12. PubMed ID: 10535489
[TBL] [Abstract][Full Text] [Related]
17. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity to M2 proteins in antimitochondrial antibody-negative patients with primary biliary cirrhosis.
Kitami N; Ishii H; Shimizu H; Adachi H; Komada T; Mikami H; Yokoi Y; Sato N
J Gastroenterol Hepatol; 1994; 9(1):7-12. PubMed ID: 8155871
[TBL] [Abstract][Full Text] [Related]
19. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.
Zhu YJ; Li J; Liu YG; Jiang Y; Cheng XJ; Han X; Wang CY; Li J
World J Gastroenterol; 2023 Sep; 29(34):5075-5081. PubMed ID: 37753365
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay.
Villalta D; Sorrentino MC; Girolami E; Tampoia M; Alessio MG; Brusca I; Daves M; Porcelli B; Barberio G; Bizzaro N;
Clin Chim Acta; 2015 Jan; 438():135-8. PubMed ID: 25172039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
